AzTrials
AzTrials

Cannabis UseCann'AppNCT07157540

Testing the Effects of Cann'App, a Digital Intervention for Cannabis Harm Reduction

A study testing Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF), Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN) and Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS) in people with Cannabis Use and Harm Reduction, run by Jacques Gaume at 1 site in Switzerland.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a digital web application can prevent the risks related to cannabis use among adult regular cannabis users who are enrolled in a pilot trial for cannabis sales regulation conducted in Lausanne, Switzerland (i.e., Cann-L study) and have agreed that their data were used in… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cannabis Use, Harm Reduction
What is being tested?
Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF), Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN) and Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
565 participants
Where
1 siteSwitzerland
Study dates
5 Jan 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Eligible participants will be those included in the pilot trial of cannabis sales regulation in Lausanne, Switzerland (Cann-L study).
  • being adult (>18 years old),
  • having current cannabis use (i.e., use at least once a month over the last 6 months)
  • living in the city of Lausanne. To enter the study, they complete an entry assessment verifying their age and proof of residence, and confirming that they have current cannabis use.

Who cannot join

  • Cann-L exclusion criteria comprise:
  • being younger than 18 years old,
  • being pregnant or breastfeeding,
  • having a health condition contraindicating the use of cannabis (e.g., severe psychiatric disorder).
  • The consent to participate in the Cann-L parent trial comprises an option to be contacted to participate in sub-studies, including studies on prevention measures. All participants having accepted to be so contacted will be proposed to participate in the present study.
  • Therefore, additional exclusion criteria for the present study include:
  • not providing informed consent to participate in sub-studies, including studies on prevention measures,
  • not providing informed consent to participate in the present study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Switzerland1 site
  • Lausanne University Hospital

    Lausanne, Vaud Canton, 1011

Other trials in Switzerland

About this study

Official title: Testing the Effects of a Digital Intervention for Cannabis Harm Reduction - The Cann'App Fractional Factorial Randomized Controlled Trial

The goal of this clinical trial is to learn if a digital web application can prevent the risks related to cannabis use among adult regular cannabis users who are enrolled in a pilot trial for cannabis sales regulation conducted in Lausanne, Switzerland (i.e., Cann-L study) and have agreed that their data were used in other studies.

The main question it aims to answer is:

Read more

Do participants who have access to the intervention modules of the web application raise their use of protective behavioral strategies to lower cannabis-related risks?

Researchers will compare the intervention modules to a control module (i.e., information on cannabis-related risks and harm reduction) to see if the web application works to prevent the risks related to cannabis use. They will also compare intervention modules across each other to see whether one works better than another.

Participants will:

  • Create a user account in the web application
  • Access the web application using a laptop, tablet or smartphone
  • Use the web application as they wish throughout the duration of the study
  • Complete the regular Cann-L study questionnaires every six months, which will be used to measure their cannabis use and related risks.
Being tested
Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF), Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN), Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS), Information
Keywords
Protective Behavioral Strategies, Cannabis Use, Digital Intervention, Adult Regular Cannabis Users, Personalized Normative Feedback, Substance-Free Activity Session, Cannabis Harm Reduction, Counterfactual Thinking, Episodic Future Thinking, Web-Based Application, Cannabis Expenditures, Cannabis Related-Consequences
Medical subject headings
Harm Reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF)Behavioural

    PF comprises the following content:

    • Self-reported PBS questionnaire, personalized feedback on PBS, possibility to select strategies to start using or use more often, possibility to set a reminder to use PBS strategies.
    • Short questionnaire on cannabis use (frequency/number of hours under the influence) and normative feedback on participant's cannabis use as compared to people of same age and gender in the general population and among Cann-L participants.
    • Question on money spent for cannabis purchase, personalized feedback (total amount spent and corresponding number of grams of cannabis over one year), gamified gauge to picture potential yearly savings, reflection on how to use the saved money, and possibility to set a reminder for money saving objectives.
    • Questionnaire on cannabis-related consequences, feedback on the level of consequences met, question about which consequence(s) participant might want to think about, and possibility to set a reminder to think about consequences.
  • Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN)Behavioural

    Two-task intervention including:

    1. Counterfactual thinking:
    • Description of a recent negative situation related to cannabis use encountered by the participant
    • Identification of a preventive strategy that would have addressed this situation
    • Writing a sentence formatted as "If only +preventive strategy, then + description on how the specific past problem would have improved"
    • Assessment of participant's intention and confidence in using the preventive strategy
    • Imagining a future situation using this preventive strategy
    • Possibility to set a reminder of the preventive strategy.
    1. Episodic future thinking:
    • Description of a significant positive event that might occur in the short-term (3 months) and that does not involve cannabis use
    • Assessment of the importance and enjoyment of this positive event
    • Encouragement to imagine it as vividly as possible
    • Suggestion to describe the positive event in detail and to write it down
    • Possibility to set a reminder of the positive event.
  • Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS)Behavioural

    SFAS includes:

    • A questionnaire on how participant value different aspects of their life, and feedback on valued domains.
    • Two open-ended questions on short- and long-term life goals.
    • A questionnaire assessing time allocation (hours per week allocated to different activities, e.g. socializing, working, etc.), and personalized feedback including the time spent using substances and recovering from their effects.
    • Gamified exercise to imagine allocating time in a different way.
    • List of substance-free recreational activities in the region of Lausanne, with possibility to select activities on a "wish-list" including internet hyperlinks.
    • Possibility to set a reminder of the selected activities.
    • Single-item questionnaire on stress and mood, and feedback on stress and mood level.
    • Open-ended question on coping strategies currently used for stress and mood.
    • List of coping strategies that can be selected.
    • Possibility to set a reminder of stress/mood coping strategies.
  • InformationBehavioural

    Minimal intervention (Control Intervention), consisting of simple, text-only web pages containing information on cannabis effects and health-related risks, cannabis consumption modes, cannabis harm reduction and protective behavioral strategies, as well as hyperlinks to additional resources and online help.

Study groups in NCT07157540
Study groupRoleWhat they receive
Condition 1 - Personalized Feedback + InformationExperimentalAccess to "Personalized Feedback" module (PF, Study Intervention) and "Information" module (Minimal, Control Intervention)
Receives: Behavioral: Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF); Behavioral: Information
Condition 2 - Imagine the future + InformationExperimentalAccess to "Imagine the Future" module (IMAGIN, Study Intervention) and "Information" module (Minimal, Control Intervention)
Receives: Behavioral: Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN); Behavioral: Information
Condition 3 - Substance-Free Activities Session + InformationExperimentalAccess to "Substance-Free Activities Session" module (SFAS, Study Intervention) and "Information" module (Minimal, Control Intervention)
Receives: Behavioral: Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS); Behavioral: Information
Condition 4 - Full Intervention + InformationExperimentalAccess to the full intervention (PF+IMAGIN+SFAS) and "Information" module (Minimal, Control Intervention)
Receives: Behavioral: Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF); Behavioral: Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN); Behavioral: Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS); Behavioral: Information
Condition 5 - Information only (Control)Active comparatorAccess to "Information" module (Minimal, Control Intervention)
Receives: Behavioral: Information

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frequency of Protective Behavioral Strategies for Marijuana Use as Measured by the PBSM-17 Short Form Scale

    This outcome will be measured using the Protective Behavioral Strategies for Marijuana Use (PBSM-17) Short Form scale, a self-reported 17-item questionnaire measuring the frequency of PBS for cannabis use on a 6-point Likert scale ranging from 1 (never) to 6 (always).

    Measured: This outcome will be assessed at 1- and 7-month follow-up.

Secondary outcomes (2)
  1. Cannabis Use Frequency

    Cannabis Use Frequency will be measured using a single item asking "During the past 30 days, on how many days did you use cannabis?"

    Measured: This outcome will be measured at 1- and 7-month follow-up.

  2. Number of Hours High on a Typical Day

    The number of hours under influence will be measured using a single item asking "How many total hours were you high on a typical day when you had been using cannabis?"

    Measured: This outcome will be measured at 1- and 7-month follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2025
  2. Study start5 Jan 2026
  3. Primary completionJul 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Model description
Monocentric 5-arm fractional factorial randomized controlled trial.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
565 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07157540
Sponsor's protocol ID
2025-00428
Other IDs
10001E_220072, 2025
Acronym
Cann'App
Status last verified
Jan 2026
First submitted
27 Aug 2025
Last updated
12 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data collected for this study may be reused and/or transmitted for other studies (including abroad), always in coded form (i.e., deidentified dataset). For each instance of reuse in another study, a data transfer agreement will need to be established.

Questions about this trial

What is this clinical trial studying?

A study testing Personalized Feedback on Cannabis Protective Behavioral Strategies, Cannabis Use, Cannabis Expenditures, and Cannabis-Related Consequences (PF), Imagining the Future Using Counterfactual Thinking and Episodic Future Thinking (IMAGIN) and Behavioral Economics-Informed Exercises to Increase Motivation to Engage in Substance-Free Activities (SFAS) in people with Cannabis Use and Harm Reduction, run by Jacques Gaume at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frequency of Protective Behavioral Strategies for Marijuana Use as Measured by the PBSM-17 Short Form Scale (time frame: This outcome will be assessed at 1- and 7-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in